Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Hospital sector may...

    Hospital sector may see 12-14 percent revenue growth over 5 years: Icra

    Written by Ruby Khatun Khatun Published On 2018-03-30T11:51:27+05:30  |  Updated On 30 March 2018 11:51 AM IST
    Hospital sector may see 12-14 percent revenue growth over 5 years: Icra

    The long-term outlook for the hospital sector is stable with annual revenues likely to grow at 12-14 percent over the next five years on rising demand and medical tourism, rating agency Icra said.


    The agency expects the growth momentum to improve the credit metrics of the companies operating in the sector.


    "The long-term outlook remains stable notwithstanding the current headwinds and regulatory challenges in the sector," it said.


    Icra expects demand to continue rising at a steady pace owing to the underlying fundamentals, including growing population, increasing life expectancy, rising incidence of non-communicable diseases related to lifestyle, and increasing health insurance coverage.


    Medical tourism is also expected to boost revenues, according to the agency, given the affordability and quality of care in the country.


    "We expect an annual revenue growth of 12-14 percent over the next five years, which is also likely to result in the improvement in credit metrics of the companies operating in the sector," it said.


    Over the last few quarters, the performance of the hospital sector has been affected due to multiple regulatory interventions in the form of demonetization, price caps on medical devices and the goods and services tax (GST).


    The performance of five listed hospital chains in the country, which together operate more than 20,000 beds suffered as a result of regulatory interventions, according to Icra.


    "In nine months of FY18, the growth in aggregate revenues of the sample set slowed down to around 9 percent against the growth of around 15 percent in the first nine months of FY17," said Shubham Jain, vice-president, Icra.


    The operating profits before interest, tax, depreciation, amortization (OPBIDTA) growth was around 15 percent in first nine months FY17, which fell sharply to minus-3 percent in first nine months FY18.


    The aggregate operating profit margins also declined from 15.1 percent in the first nine months FY17 to 13.7 percent in the first nine months of FY18, resulting in the decline in absolute OPBIDTA from Rs 15.02 billion to Rs 14.90 billion during the same period.


    Jain noted that additionally, on a year on year basis, all quarters of the first nine months FY18 saw weaker revenue growth and decline of over 100 bps in operating margin.


    According to Icra, a major development for the industry has been the announcement of the National Health Protection Scheme (NHPS) in the 2018-19 budget that envisages health insurance cover for 100 million families (around 500 million beneficiaries) for a sum of up to Rs 0.5 million per family per year.


    "Launch of a government-funded healthcare plan of this scale has the potential to significantly increase the healthcare spend in the country," it said.


    The agency expects the introduction of NHPS to likely improve the occupancies at implementing hospitals albeit with lower profit margins.


    Jain said regulatory intervention in terms of pricing caps are expected to continue to exert pressure on the margins in the near term.


    "However, the hospitals may gradually offset these costs over the medium term by a general hike in tariffs and by re-looking at the pricing of various procedures, products, and services," he added.

    Goods and Services Taxgrowthhealth insuranceHospital sectorICRAMedical DevicesMedical TourismNational Health Protection SchemeNon Communicable Diseasesrevenue
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok